
About Oncofocus
Oncofocus is a Healthcare company based in India founded in 2014. It provides oncology research, consulting, AI platforms, and competitive intelligence services. It operates on a B2B and SaaS model in Healthcare and Technology sectors. The company has 19 employees. Its Indian entity Oncofocus Solutions Private Limited reported revenue of ₹2.82 Cr. Oncofocus offers products and services including CImple, Novus AI, and CGT Watch. Its focus areas include Oncology, Drug Development, Competitive Intelligence and AI Platforms.
Company details
Oncofocus is an oncology-focused consulting firm that delivers strategic insights, competitive intelligence, and AI-powered tools to support drug development from preclinical to commercialization stages. They analyze competitor activities, track clinical trends, and provide platforms like CImple for strategic planning. Based in Bengaluru, India, they serve biotech firms with actionable intelligence to aid decision-making and asset prioritization.
- Headquarters India
- Employees 19
- SectorsHealthcareTechnology
- Email••••••••
- Website oncofocus.com
- Social LinkedIn X Facebook YouTube
- Legal Name Oncofocus Solutions Private Limited
- Date of Incorporation 01 Jan, 2014
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹2.82 Cr
FY 2025 · +19% YoY
- Net Profit₹9.2 Lakh
FY 2025 · 3% margin
- EBITDA₹14.3 Lakh
FY 2025 · 5% margin
- Employee Count19
Associated legal entities of Oncofocus
Oncofocus operates through Oncofocus Solutions Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Oncofocus Solutions Private Limited CIN U74200KA2014PTC072812 | Active | 01 Jan 2014 | Bangalore, Karnataka | ₹2.8 Cr | 19 | 2 | View details |
Products & Services of Oncofocus
Oncofocus offers a comprehensive portfolio of products and services, including CImple, Novus AI, and CGT Watch.
Platform for oncology strategic insights and decision support.
Tool for analyzing conference data in oncology.
Platform for cell and gene therapy intelligence tracking.
Apps and channels of Oncofocus
its YouTube channel Oncofocus Solutions has 7 subscribers and 4 videos.
Videos from Oncofocus
The most watched videos on Oncofocus's YouTube channel, Oncofocus Solutions (7 subscribers). Click a video to play it here.
More on Oncofocus Solutions.
Board of directors of Oncofocus Solutions Private Limited (Oncofocus)
Oncofocus Solutions Private Limited is the primary company behind Oncofocus. The board of Oncofocus Solutions Private Limited currently have 2 directors; the longest-serving is Ashish Shukla, appointed in 2014.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ashish Shukla DIN 06758023 | Director | 01 Jan 2014 | 12 yrs 9 mo | Oncofocus Solutions Private Limited |
| Vimla Shukla DIN 06758028 | Director | 01 Jan 2014 | 12 yrs 9 mo | Oncofocus Solutions Private Limited |
Financials of Oncofocus
Figures of Oncofocus Solutions Private Limited, the primary company behind Oncofocus, for FY 2025. Revenue was ₹2.82 Cr (+19% year on year). Net profit was ₹9.2 Lakh (3% margin). EBITDA was ₹14.3 Lakh (5% margin). Revenue has grown at a compounded annual rate of +19% over three years and +28% over five years.
- ₹2.82 CrRevenue · FY 2025 · +19% YoY
- ₹9.2 LakhNet profit · 3% margin
- ₹14.3 LakhEBITDA · 5% margin
- ₹1 LakhPaid-up capital
- 19Employees (provident fund records)
- +19%Revenue CAGR, 3 years
- +28%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Oncofocus Solutions Private Limited are on its company page.
Detailed financial statements for Oncofocus
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Oncology Informatics
3 companies that operate in the same segment as Oncofocus (Oncology Informatics) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provides AI-driven IT services for healthcare data integration and custom development. | 2015 | Guwahati, Assam, India | ||||
Provides comprehensive software solutions for clinical analytics. | 2014 | Mumbai, Maharashtra, India | USD 521.52 K | 12 | ||
Provides AI, machine learning, and software development for healthcare data insights. | 2008 | Bengaluru, Karnataka, India |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Oncofocus
Oncofocus was founded in 2014.
Oncofocus is headquartered in India.
Oncofocus has 19 employees.
The primary company behind Oncofocus, Oncofocus Solutions Private Limited, reported revenue of ₹2.82 Cr for FY 2025, up 19% year on year.
Oncofocus is an oncology-focused consulting firm that delivers strategic insights, competitive intelligence, and AI-powered tools to support drug development from preclinical to commercialization stages. They analyze competitor activities, track clinical trends, and provide platforms like CImple for strategic planning. Based in Bengaluru, India, they serve biotech firms with actionable intelligence to aid decision-making and asset prioritization.
Oncofocus offers CImple, Novus AI, and CGT Watch.
Oncofocus operates through Oncofocus Solutions Private Limited.
The legal entities of Oncofocus currently have 2 directors, including Ashish Shukla, Vimla Shukla.